asthma (non-acute) management Flashcards
pre-school wheeze is classified by what 2 criteria
flare-up severity
symptom frequency
pre-school wheeze - define levels of flare-up severity
mild - managed in community with LABA
moderate - needed steroids or ED
severe - hospitalization or PICU
pre-school wheeze - define levels of symptom frequency
symptoms 1 / >6 months
symptoms 1 / >3-4 monthly
symptoms 1 / >4-6 weekly
symptoms >1 day / week
pre-school wheeze - which patients should have preventer therapy
anyone who has had moderate or severe flare-up
mild flare-ups > 1 / 4-6 weeks
asthma - factors increasing risk of flare-up (3 sx. related, 1 disease related, 2 lifestyle related, 1 rx. related)
- poor asthma control
- having a flare-up 12 months before
- not able to tell how dyspnoeic they are
- other lung disease present
- being poor, drug use, psychosocial problems, mental illness
- smoking and environmental exposure
- using 3 SABA MDIs per year
asthma - factors increasing risk of life-threatening flare-up (4 hosp related, 2 rx relate, 2 disease related)
- in ED 3 times for asthma last year
- in hospital twice for asthma in last year
- hospital or ED in last month
- delaying hospital
- being intubated in the past for asthma
- using 12 saba mdis per year increases risk of death
- sudden-onset acute asthma
- CVD
asthma in 14+ patients - assessing symptom control (5)
- symptoms affecting daily activities
- frequency of feeling dypsnoeic
- frequency of waking at night with symptoms
- frequency of reliever inhaler use
- subjective feeling of asthma control
asthma in 6-11 - indications for preventer therapy (5)
definite
- persistent asthma
- life-threatening flare-up
- moderate severity, frequent intermittent
consider
mild flare-ups + frequent
moderate-severe flare-ups, infrequent
asthma in 6-11 - frequency categories (3)
infrequent - 6 weeks or longer per attack
frequent intermittent - attacks every 4-6 weeks
persistent - day symptoms once /week, night symptoms twice a month or symptoms affecting activity or sleep
asthma in 6-11 - flare-up severity categories (3)
mild - community managed w/ salbutamol
moderate-severe - >2 episodes needing ED or oral steorids
life-threatening - hospital or PICU
asthma in 6-11 - stepped approach to escalating dose
SABA -> flixotide 50 microg 1-2 BD or montelukast 5mg -> add the other | high dose ICS | seretide 100/25 BD | refer
montelukast dosage in ages 1-5
4mg
montelukast dosage in ages 6-13
5mg
montelukast dosages in 14+
10mg
risk factors to develop asthma (9)
genetic
- family history of asthma and allergies (esp maternal)
medical history
- past history of atopy and food allergies in early life
- low birth weight
- obesity
tobacco
- in-utero tobacco exposure
- tobacco smoking
- environmental tobacco smoke
environment
- environmental pollution
- work-related exposure